Fraunhofer IME ScreeningPort

The Fraunhofer Institute for Molecular Biology and Applied Ecology IME conducts research in the field of applied life sciences from a molecular level to entire ecosystems.

The mission of Fraunhofer IME ScreeningPort (IME-SP) is to bridge the gap between basic academic research and the life sciences industry in the field of drug discovery and development. With state-of-the-art infrastructure at its location in Hamburg, established processes and innovative technologies, IME-SP positioned itself as a world-leading research partner for small-molecule screening.

The IME-SP directs its efforts onto the development of biological assay systems, high-throughput drug discovery (i.e. high-throughput screening, high-content screening and virtual screening), the identification of diagnostic biomarkers (including those used for companion diagnostics in preclinical/clinical studies) and pharmacological bioinformatics.

The Fraunhofer IME has approximately 600 employees working at its laboratories in Aachen, Schmallenberg, Münster, Gießen, Frankfurt and Hamburg as well as subsidiary research centers in the USA and in Chile.

K4DD aims at converting knowledge of binding kinetics in to data-driven guidelines and easily accessible assay tools and technologies for future drug discovery. IME-SP is working across all three scientific workpackages of the project, that aim to i) increase the molecular understanding of drug target interactions, ii) develop novel assays and technologies for screening approaches and iii) to develop predictive modeling approaches for the translation of the gained knowledge into In vivo models.